As of 2025-07-16, the Gross Margin of Concord Drugs Ltd (538965.BO) is 22.1%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2025-03-31 | 22.1% |
2024-03-31 | 26% |
2023-03-31 | 21.3% |
2022-03-31 | 28.6% |
2021-03-31 | 17.9% |
2020-03-31 | 17.1% |
2019-12-31 | 19.8% |
2019-09-30 | 19.8% |
2019-06-30 | 16.2% |
2019-03-31 | 17% |